Search Results - "воспалительные заболевания"

Source: VII Пущинская конференция «Биохимия, физиология и биосферная роль микроорганизмов», шко- ла-конференция для молодых ученых, аспирантов и студентов «Генетические технологии в микробио- логии и микробное разнообразие».

Subject Terms: микробиом, воспалительные заболевания кишечника

8

Academic Journal

PURULENT EPIDURITIS: CASE HISTORY IN GENERAL PRACTITIONER PRACTICE

Authors: Natalia A. Dvoynikova, Lyudmila A. Bulgatova, Natalya Yu. Alekseeva

Source: Байкальский медицинский журнал, Vol 3, Iss 4, Pp 50-58 (2024)

Subject Terms: гнойно-воспалительные заболевания позвоночника, эпидурит, антибактериальная терапия, Medicine (General), R5-920

File Description: electronic resource

Relation: https://www.bmjour.ru/jour/article/view/240; https://doaj.org/toc/2949-0715

Access URL: https://doaj.org/article/8ce0f00c97fc40d6a8d918ef3401eb07

View record in DOAJ

9

Academic Journal

The impact of telemonitoring on the psychological well-being of patients with inflammatory bowel disease: a prospective randomized controlled study ; Телемониторинг как инструмент влияния на психологическое состояние пациентов с воспалительными заболеваниями кишечника: проспективное рандомизированное контролируемое исследование

Authors: Akhmedzyanova D.A., Shumskaya Y.F., Vladzymyrskyy A.V., Mnatsakanyan M.G., Reshetnikov R.V.

Contributors: 0

Source: Almanac of Clinical Medicine; Vol 53, No 4 (2025); 180-193 ; Альманах клинической медицины; Vol 53, No 4 (2025); 180-193 ; 2587-9294 ; 2072-0505

Subject Terms: inflammatory bowel disease, telemonitoring, psychological well-being, depression and anxiety, воспалительные заболевания кишечника, телемониторинг, психологическое состояние, тревога и депрессия

File Description: application/pdf

Availability: https://almclinmed.ru/jour/article/view/17479
https://doi.org/10.18786/2072-0505-2025-53-016

View record from BASE

10

Academic Journal

Deciphering crucial genes in pelvic inflammatory disease and their relationship with infertility through systems biology studies ; Системная биология в расшифровке критических генов в воспалительных заболеваниях органов малого таза и их связи с бесплодием

Authors: Saberi F., Dehghan Z., Pilehchi T., Mehdinejadiani S., Taheri Z., Zali H.

Contributors: 0

Source: Russian Journal of Infection and Immunity; Vol 15, No 4 (2025); 664-672 ; Инфекция и иммунитет; Vol 15, No 4 (2025); 664-672 ; 2313-7398 ; 2220-7619

Subject Terms: pelvic inflammatory disease, infertility, bacterial infections, protein-protein interaction network, gene regulatory network, computational biology, воспалительные заболевания органов малого таза, бесплодие, бактериальные инфекции, сеть белок-белкового взаимодействия, сеть регуляции генов, вычислительная биология

File Description: application/pdf

Availability: https://iimmun.ru/iimm/article/view/17845
https://doi.org/10.15789/2220-7619-DCG-17845

View record from BASE

11

Academic Journal

STUDY OF ZINC OXIDE NANOPARTICLE-BASED SUPPOSITORIES: IN VITRO ANTIMICROBIAL ACTIVITY AND APPLICATION PROSPECTS ; ИЗУЧЕНИЕ СУППОЗИТОРИЕВ С НАНОЧАСТИЦАМИ ОКСИДА ЦИНКА: АНТИМИКРОБНАЯ АКТИВНОСТЬ IN VITRO И ПЕРСПЕКТИВЫ ПРИМЕНЕНИЯ

Authors: Алимджанова , Лола, Шерматова , Ирода, Хусниддинова , Азизахон, Сафокулов , Бобур

Source: Eurasian Journal of Medical and Natural Sciences; Vol. 5 No. 8 (2025): Eurasian Journal of Medical and Natural Sciences; 80-85 ; Евразийский журнал медицинских и естественных наук; Том 5 № 8 (2025): Евразийский журнал медицинских и естественных наук; 80-85 ; Yevrosiyo tibbiyot va tabiiy fanlar jurnali; Jild 5 Nomeri 8 (2025): Евразийский журнал медицинских и естественных наук; 80-85 ; 2181-287X

Subject Terms: Scutellaria Iscanderi L., наночастицы оксида цинка (ZnO-NPs), антимикробная активность, in vitro, суппозитории, инфекционно-воспалительные заболевания, растительный экстракт, местное лечение, zinc oxide nanoparticles (ZnO-NPs), antimicrobial activity, suppositories, infectious-inflammatory diseases, herbal extract, local treatment

File Description: application/pdf

Relation: https://in-academy.uz/index.php/EJMNS/article/view/58899/37140

Availability: https://in-academy.uz/index.php/EJMNS/article/view/58899

View record from BASE

12

Academic Journal

Necrotizing Enterocolitis: Pathogenetic Features and Differential Diagnosis with Inflammatory Bowel Disease in Newborns ; Некротизирующий энтероколит: особенности патогенеза и дифференциальная диагностика с воспалительными заболеваниями кишечника у новорожденных

Authors: Aleksandra V. Kaplina, Nataliya A. Petrova, Tatiana M. Pervunina, Anatoly I. Khavkin, Andrey N. Surkov, Lyudmila P. Nazarenko, Stanislav D. Getmanov, Stanislav I. Sitkin, А. В. Каплина, Н. А. Петрова, Т. М. Первунина, А. И. Хавкин, А. Н. Сурков, Л. И. Назаренко, С. Д. Гетманов, С. И. Ситкин

Contributors: Not specified., Отсутствует

Source: Current Pediatrics; Том 23, № 6 (2024); 438-446 ; Вопросы современной педиатрии; Том 23, № 6 (2024); 438-446 ; 1682-5535 ; 1682-5527

Subject Terms: болезнь Крона, preterm neonates, very early onset inflammatory bowel disease, ulcerative colitis, Crohn’s disease, недоношенные новорожденные, воспалительные заболевания кишечника с очень ранним началом, язвенный колит

File Description: application/pdf

Relation: https://vsp.spr-journal.ru/jour/article/view/3652/1414; Niño DF, Sodhi CP, Hackam DJ. Necrotizing enterocolitis: new insights into pathogenesis and mechanisms. Nat Rev Gastroenterol Hepatol. 2016;13(10):590–600. doi: https://doi.org/10.1038/nrgastro.2016.119; Ginglen JG, Butki N. Necrotizing Enterocolitis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024.; Alsaied A, Islam N, Thalib L. Global incidence of Necrotizing Enterocolitis: a systematic review and Meta-analysis. BMC Pediatr. 2020;20(1):344. doi: https://doi.org/10.1186/s12887-020-02231-5; Zozaya C, García González I, Avila-Alvarez A, et al. Incidence, Treatment, and Outcome Trends of Necrotizing Enterocolitis in Preterm Infants: A Multicenter Cohort Study. Front Pediatr. 2020;8:188. doi: https://doi.org/10.3389/fped.2020.00188; Ouahed J, Spencer E, Kotlarz D, et al. Very Early Onset Inflammatory Bowel Disease: A Clinical Approach With a Focus on the Role of Genetics and Underlying Immune Deficiencies. Inflamm Bowel Dis. 2020;26(6):820–842. doi: https://doi.org/10.1093/ibd/izz259.; Uhlig HH, Schwerd T, Koletzko S, et al. The diagnostic approach to monogenic very early onset inflammatory bowel disease. Gastroenterology. 2014;147(5):990–1007.e3. https://doi.org/10.1053/j.gastro.2014.07.023; Kuenzig ME, Fung SG, Marderfeld L, et al. Twenty-first Century Trends in the Global Epidemiology of Pediatric-Onset Inflammatory Bowel Disease: Systematic Review. Gastroenterology. 2022;162(4):1147–1159.e4. doi: https://doi.org/10.1053/j.gastro.2021.12.282; Корниенко Е.А. Воспалительные заболевания кишечника у детей. — М.: Прима Принт; 2019.; Шапкина О.А., Федулова Э.Н., Лаврова А.Е., Шабунина Е.И. Научно-практические аспекты эпидемиологических исследований воспалительных заболеваний кишечника у детей Приволжского Федерального округа // Педиатрия. Журнал им. Г.Н. Сперанского. — 2016. — Т. 95. — № 6. — С. 50–55.; Белоусова Е.А., Шелыгин Ю.А., Ачкасов С.И. и др. Клиникодемографические характеристики и лечебные подходы у пациентов с воспалительными заболеваниями кишечника (болезнь Крона, язвенный колит) в РФ. Первые результаты анализа Национального Регистра // Колопроктология. — 2023. — Т. 22. — № 1. — С. 65–82. — doi: https://doi.org/10.33878/2073-7556-2023-22-1-65-82; Cannioto Z, Berti I, Martelossi S, et al. IBD and IBD mimicking enterocolitis in children younger than 2 years of age. Eur J Pediatr. 2009;168(2):149–155. doi: https://doi.org/10.1007/s00431-008-0721-2; Parente P, Pastore M, Grillo F, et al. Very Early Onset-IBD: evidence for the need of a multidisciplinary approach. Pathologica. 2022;114(1):3–11. doi: https://doi.org/10.32074/1591-951X-336; Underwood MA. Paneth cells and necrotizing enterocolitis. Gut Microbes. 2012;3(6):562–565. doi: https://doi.org/10.4161/gmic.21738; Demers-Mathieu V. The immature intestinal epithelial cells in preterm infants play a role in the necrotizing enterocolitis pathogenesis: A review. Health Sciences Review. 2022;4:100033. doi: https://doi.org/10.1016/j.hsr.2022.100033; Leaphart CL, Cavallo J, Gribar SC, et al. A critical role for TLR4 in the pathogenesis of necrotizing enterocolitis by modulating intestinal injury and repair. J Immunol. 2007;179(7):4808–4820. doi: https://doi.org/10.4049/jimmunol.179.7.4808; Gribar SC, Sodhi CP, Richardson WM, et al. Reciprocal expression and signaling of TLR4 and TLR9 in the pathogenesis and treatment of necrotizing enterocolitis. J Immunol. 2009;182(1):636–646. doi: https://doi.org/10.4049/jimmunol.182.1.636; Sodhi CP, Shi XH, Richardson WM, et al. Toll-like receptor-4 inhibits enterocyte proliferation via impaired beta-catenin signaling in necrotizing enterocolitis. Gastroenterology. 2010;138(1): 185–196. doi: https://doi.org/10.1053/j.gastro.2009.09.045; Hackam DJ, Sodhi CP. Toll-Like Receptor-Mediated Intestinal Inflammatory Imbalance in the Pathogenesis of Necrotizing Enterocolitis. Cell Mol Gastroenterol Hepatol. 2018;6(2): 229–238.e1. doi: https://doi.org/10.1016/j.jcmgh.2018.04.001; Good M, Sodhi CP, Yamaguchi Y, et al. The human milk oligosaccharide 2'-fucosyllactose attenuates the severity of experimental necrotising enterocolitis by enhancing mesenteric perfusion in the neonatal intestine. Br J Nutr. 2016;116(7): 1175–1187. doi: https://10.1017/S0007114516002944; Neal MD, Sodhi CP, Dyer M, et al. A critical role for TLR4 induction of autophagy in the regulation of enterocyte migration and the pathogenesis of necrotizing enterocolitis. J Immunol. 2013;190(7):3541–3551. doi: https://doi.org/10.4049/jimmunol.1202264; Sodhi CP, Wipf P, Yamaguchi Y, et al. The human milk oligosaccharides 2'-fucosyllactose and 6’-sialyllactose protect against the development of necrotizing enterocolitis by inhibiting toll-like receptor 4 signaling. Pediatr Res. 2021;89(1):91–101. doi: https://doi.org/10.1038/s41390-020-0852-3; Cai X, Golubkova A, Hunter CJ. Advances in our understanding of the molecular pathogenesis of necrotizing enterocolitis. BMC Pediatr. 2022;22(1):225. doi: https://doi.org/10.1186/s12887-022-03277-3; Xia X, Wang D, Yu L, et al. Activated M1 macrophages suppress c-kit expression via TNF-a-mediated upregulation of miR-222 in Neonatal Necrotizing Enterocolitis. Inflamm Res. 2021;70(3): 343–358. doi: https://doi.org/10.1007/s00011-021-01441-6; Schreurs RRCE, Baumdick ME, Sagebiel AF, et al. Human Fetal TNF-a-Cytokine-Producing CD4+ Effector Memory T Cells Promote Intestinal Development and Mediate Inflammation Early in Life. Immunity. 2019;50(2):462–476.e8. doi: https://doi.org/10.1016/j.immuni.2018.12.010; Pang Y, Du X, Xu X, et al. Impairment of regulatory T cells in patients with neonatal necrotizing enterocolitis. Int Immunopharmacol. 2018;63:19–25. doi: https://doi.org/10.1016/j.intimp.2018.07.029; Weitkamp JH, Koyama T, Rock MT, et al. Necrotising enterocolitis is characterised by disrupted immune regulation and diminished mucosal regulatory (FOXP3)/effector (CD4, CD8) T cell ratios. Gut. 2013;62(1):73–82. doi: https://doi.org/10.1136/gutjnl-2011-301551; Gephart SM, Gordon PV, Penn AH, et al. Changing the paradigm of defining, detecting, and diagnosing NEC: Perspectives on Bell’s stages and biomarkers for NEC. Semin Pediatr Surg. 2018;27(1): 3–10. doi: https://doi.org/10.1053/j.sempedsurg.2017.11.002; Patel RM, Ferguson J, McElroy SJ, et al. Defining necrotizing enterocolitis: current difficulties and future opportunities. Pediatr Res. 2020;88(Suppl 1):10–15. doi: https://doi.org/10.1038/s41390-020-1074-4; Gordon PV, Swanson JR, MacQueen BC, Christensen RD. A critical question for NEC researchers: Can we create a consensus definition of NEC that facilitates research progress? Semin Perinatol. 2017;41(1):7–14. doi: https://doi.org/10.1053/j.semperi.2016.09.013; Khashu M, Dame C, Lavoie PM, et al. Current Understanding of Transfusion-associated Necrotizing Enterocolitis: Review of Clinical and Experimental Studies and a Call for More Definitive Evidence. Newborn (Clarksville). 2022;1(1):201–208. doi: https://doi.org/10.5005/jp-journals-11002-0005; Nakib G, Sajwani S, Abusalah Z, et al. Recurrent supraventricular tachycardia and necrotizing enterocolitis: A causative role or a simple association? A case report and literature review. Pediatr Rep. 2018;10(3):7636. doi: https://doi.org/10.4081/pr.2018.7636; Mecarini F, Comitini F, Bardanzellu F, et al. Neonatal supraventricular tachycardia and necrotizing enterocolitis: case report and literature review. Ital J Pediatr. 2020;46(1):117. doi: https://doi.org/10.1186/s13052-020-00876-7; Fisher JG, Bairdain S, Sparks EA, et al. Serious congenital heart disease and necrotizing enterocolitis in very low birth weight neonates. J Am Coll Surg. 2015;220(6):1018–1026.e14. doi: https://doi.org/10.1016/j.jamcollsurg.2014.11.026; Siano E, Lauriti G, Ceccanti S, Zani A. Cardiogenic Necrotizing Enterocolitis: A Clinically Distinct Entity from Classical Necrotizing Enterocolitis. Eur J Pediatr Surg. 2019;29(1):14–22. doi: https://doi.org/10.1055/s-0038-1668144; Дорофеева Е.И., Подуровская Ю.Л., Буров А.А. и др. Диагностика и консервативное лечение новорожденных с некротизирующим энтероколитом: клинические рекомендации. 2014. https://neonatology.pro/wp-content/uploads/2014/08/Protokol_NEC_2014.pdf.; Kappelman MD, Grand RJ. Does inflammatory bowel disease develop in infants? Inflamm Bowel Dis. 2008;14(Suppl 2):S6–S8. doi: https://doi.org/10.1002/ibd.20544; Feldens L, Souza JCK, Fraga JC. There is an association between disease location and gestational age at birth in newborns submitted to surgery due to necrotizing enterocolitis. J Pediatr (Rio J). 2018;94(3):320–324. doi: https://doi.org/10.1016/j.jped.2017.06.010; Ebrahimi S MS, Khademi G MD, Jafari SA MD, et al. Neonatal Presentation of Unremitting Inflammatory Bowel Disease. Iran J Med Sci. 2018;43(3):328–331.; Шумилов П.В., Щиголева А.Е. Особенности воспалительных заболеваний кишечника с очень ранним началом: опыт федерального педиатрического центра // Вопросы детской диетологии. — 2021. — Т. 19. — № 3. — С. 5–13. — doi: https://doi.org/10.20953/1727-5784-2021-3-5-13; Щиголева А.Е. Воспалительные заболевания кишечника с очень ранним началом у детей: особенности диагностики и лечения: дис. . канд. мед. наук. — М.; 2020.; Яблокова Е.А, Джабарова А.К., Лохматов М.М. и др. Внекишечные проявления воспалительных заболеваний кишечника у детей // Экспериментальная и клиническая гастроэнтерология. — 2023. — Т. 209. — № 1. — С. 165–177. — doi: https://doi.org/10.31146/1682-8658-ecg-209-1-165-177; Kaplina A, Kononova S, Zaikova E, et al. Necrotizing Enterocolitis: The Role of Hypoxia, Gut Microbiome, and Microbial Metabolites. Int J Mol Sci. 2023;24(3):2471. doi: https://doi.org/10.3390/ijms24032471; Conrad MA, Bittinger K, Ren Y, et al. The intestinal microbiome of inflammatory bowel disease across the pediatric age range. Gut Microbes. 2024;16(1):2317932. doi: https://doi.org/10.1080/19490976.2024.2317932; Каплина А.В., Азаров Д.В., Петрова Н.А. и др. Особенности микробиома кишечника при некротизирующим энтероколите у недоношенных новорожденных и доношенных новорожденных с врожденными пороками сердца по данным метагеномного секвенирования // Вопросы практической педиатрии. — 2023. — Т. 18. — № 6. — С. 68–83. — doi: https://doi.org/10.20953/1817-7646-2023-6-68-83; Nakaya K, Iinuma Y, Hirayama Y, et al. A Case of a Two-MonthOld Boy Diagnosed with Infantile Crohn’s Disease Based on an Atypical Perianal Lesion. Case Rep Pediatr. 2020;2020:8832856. doi: https://doi.org/10.1155/2020/8832856; Iida C, Tatsumi A, Fujino H, et al. Infantile Inflammatory Bowel Disease in a Three-Month-Old-Boy. Cureus. 2021;13(1):e12743. doi: https://doi.org/10.7759/cureus.12743; Коновалова А.М., Печкуров Д.В., Тяжева А.А. Хроническая диарея как симптом дебюта болезни Крона у ребенка первого года жизни: клинический случай // Вопросы современной педиатрии. — 2023. — Т. 22. — № 1. — С. 68–72. — doi: https://doi.org/10.15690/vsp.v22i1.2518; Xu L, Lochhead P, Ko Y, et al. Systematic review with metaanalysis: breastfeeding and the risk of Crohn’s disease and ulcerative colitis. Aliment Pharmacol Ther. 2017;46(9):780–789. doi: https://doi.org/10.1111/apt.14291; Canova C, Ludvigsson JF, Di Domenicantonio R, et al. Perinatal and Antibiotic Exposures and the Risk of Developing ChildhoodOnset Inflammatory Bowel Disease: A Nested Case-Control Study Based on a Population-Based Birth Cohort. Int J Environ Res Public Health. 2020;17(7):2409. doi: https://doi.org/10.3390/ijerph17072409; Agrawal M, Sabino J, Frias-Gomes C, et al. Early life exposures and the risk of inflammatory bowel disease: Systematic review and meta-analyses. EClinicalMedicine. 2021;36:100884. doi: https://doi.org/10.1016/j.eclinm.2021.100884; Miró-González ÁA, Maldonado-Chaar SM, ZambranaValenzuela R, et al. Development of Very-Early-Onset Inflammatory Bowel Disease After Multiple Early-Life Antibiotic Exposures: A Case Report and Literature Review. Cureus. 2023;15(1):e33813. doi: https://doi.org/10.7759/cureus.33813; Velosa M, Hochner H, Yerushalmi B, et al. Pre- and Perinatal Factors Predicting Inflammatory Bowel Disease: A PopulationBased Study with Fifty Years of Follow-Up. J Crohns Colitis. 2022;16(9):1397–1404. doi: https://doi.org/10.1093/ecco-jcc/jjac043; Kozuch P. Two Cases of Crohn’s Disease in the Setting of past Necrotizing Enterocolitis: 943. Am J Gastroenterol. 2008;103: S370–S371.; Carnell C, McHugh J, Lincango E, Holubar S. S18 Crohn’s Jejunoileitis in an Adult Patient With Prior Enterectomy After Necrotizing Enterocolitis: A Case Mandating Bowel Preserving Surgery. Am J Gastroenterol. 2022;117(1):S5. doi: https://doi.org/10.14309/01.ajg.0000897580.29305.ab; Ащеулова А.П., Левчук Л.В. Случай болезни Крона у ребенка с синдромом короткой кишки после хирургической коррекции нейроинтестинальной дисплазии // Актуальные вопросы современной медицинской науки и здравоохранения: материалы VI Международной научно-практической конференции молодых учёных и студентов. — Екатеринбург: Изд-во УГМУ; 2021. — С. 271–276.; Cuna A, George L, Sampath V. Genetic predisposition to necrotizing enterocolitis in premature infants: Current knowledge, challenges, and future directions. Semin Fetal Neonatal Med. 2018;23(6): 387–393. doi: https://doi.org/10.1016/j.siny.2018.08.006; Jilling T, Ambalavanan N, Cotten CM, et al. Surgical necrotizing enterocolitis in extremely premature neonates is associated with genetic variations in an intergenic region of chromosome 8. Pediatr Res. 2018;83(5):943–953. doi: https://doi.org/10.1038/pr.2018.33; Tremblay É, Thibault MP, Ferretti E, et al. Gene expression profiling in necrotizing enterocolitis reveals pathways common to those reported in Crohn’s disease. BMC Med Genomics. 2016;9:6. doi: https://doi.org/10.1186/s12920-016-0166-9; Корниенко Е.А., Крупина А.Н., Габрусская Т.В., Калинина Н.М. Воспалительные заболевания кишечника с очень ранним началом // Альманах клинической медицины. — 2016. — Т. 44. — № 6. — С. 719–733. — doi: https://doi.org/10.18786/2072-0505-2016-44-6-719-733; Zheng HB, de la Morena MT, Suskind DL. The Growing Need to Understand Very Early Onset Inflammatory Bowel Disease. Front Immunol. 2021;12:675186. doi: https://doi.org/10.3389/fimmu.2021.675186; Kornienko EA, Krupina AN, Kalinina NM, Bychkova NV. Osobennosti immunologicheskogo statusa u detey s vospalitel’nymi zabolevaniyami kishechnika. Gastroenterologiya Sankt-Peterburga. 2018;(2):73–73b. (In Russ).

Availability: https://vsp.spr-journal.ru/jour/article/view/3652
https://doi.org/10.15690/vsp.v23i6.2830

View record from BASE

13

Academic Journal

Potential of Using Walnuts as a Part of Nutritional Therapy for Inflammatory Bowel Diseases ; Перспективы использования грецких орехов в качестве компонента диетотерапии при воспалительных заболеваниях кишечника

Authors: Andrew V. Nalyotov, Anatoly I. Khavkin, Alexander N. Matsynin, Vera S. Strionova, А. В. Налетов, А. И. Хавкин, А. Н. Мацынин, В. С. Стрионова

Contributors: Not specified., Отсутствует.

Source: Pediatric pharmacology; Том 22, № 1 (2025); 56–61 ; Педиатрическая фармакология; Том 22, № 1 (2025); 56–61 ; 2500-3089 ; 1727-5776

Subject Terms: антиоксидантные свойства, inflammatory bowel diseases, microbiota, anti-inflammatory effect, antioxidant properties, воспалительные заболевания кишечника, микробиота, противовоспалительный эффект

File Description: application/pdf

Relation: https://www.pedpharma.ru/jour/article/view/2578/1674; Wang R, Li Z, Liu S, Zhang D. Global, regional and national burden of inflammatory bowel disease in 204 countries and territories from 1990 to 2019: a systematic analysis based on the Global Burden of Disease Study 2019. BMJ Open. 2023;13(3):e065186. doi: https://doi.org/10.1136/bmjopen-2022-065186; Хавкин А.И., Налетов А.В., Масюта Д.И., Махмутов Р.Ф. Роль витамина D в патогенезе воспалительных заболеваний кишечника: обзор литературы // Вопросы современной педиатрии. — 2024. — Т. 23. — № 2. — С. 58–62. — doi: https://doi.org/10.15690/vsp.v23i2.2722; Хавкин А.И., Налетов А.В., Шумилов П.В. Значение омиксных технологий в диагностике болезни Крона // Вопросы детской диетологии. — 2024. — Т. 22. — № 4. — С. 46–53. — doi: https://doi.org/10.20953/1727-5784-2024-4-46-53; Хавкин А.И., Налетов А.В., Марченко Н.А. Воспалительные заболевания кишечника у детей: современные достижения в диагностике и терапии // Российский журнал гастроэнтерологии, гепатологии, колопроктологии. — 2023. — Т. 33. — № 6. — С. 7–15. — doi: https://doi.org/10.22416/1382-4376-2023-33-6-7-15; Корниенко Е.А., Хавкин А.И., Федулова Е.Н. и др. Проект рекомендаций российского общества детских гастроэнтерологов, гепатологов и нутрициологов по диагностике и лечению болезни Крона у детей // Экспериментальная и клиническая гастроэнтерология. — 2019. — Т. 171. — № 11. — С. 100–134. — doi: https://doi.org/10.31146/1682-8658-ecg-171-11-100-134; Налетов А.В., Хавкин А.И., Мацынин А.Н. Куркумин — перспективы использования в лечении заболеваний органов пищеварения // Children’s Medicine of the North-West. — 2024. — Т. 12. — № 3. — С. 49–56. — doi: https://doi.org/10.56871/CmN-W.2024.45.37.006; Хавкин А.И., Налетов А.В., Мацынина М.А. Противовоспалительные эффекты оливкового масла и его компонентов. Перспективы применения в лечении воспалительных заболеваний кишечника // Педиатрическая фармакология. — 2024. — Т. 21. — № 3. — С. 249–255. — doi: https://doi.org/10.15690/pf.v21i3.2754; Nakanishi M, Matz A, Klemashevich C, et al. Walnut supplementation alters mucosal metabolite profiles during DSS-induced colonic ulceration. Nutrients. 2019;11(5):1118. doi: https://doi.org/10.3390/nu11051118; Ni ZJ, Zhang YG, Chen SX, et al. Exploration of walnut components and their association with health effects. Crit Rev Food Sci Nutr. 2021;62(19):5113–5129. doi: https://doi.org/10.1080/10408398.2021.1881439; Налётов А.В., Хавкин А.И., Мацынина М.А., Москалюк О.Н. Орехи — важный компонент здорового питания // Вопросы диетологии. — 2024. — Т. 14 — № 4. — С. 42–47. — doi: https://doi.org/10.20953/2224-5448-2024-4-42-47; Хавкин А.И., Богданова Н.М., Новикова В.П. Биологическая роль зонулина и эффективность его использования в качестве биомаркера синдрома повышенной кишечной проницаемости // Российский вестник перинатологии и педиатрии. — 2021. — Т. 66. — № 1. — С. 31–38. — doi: https://doi.org/10.21508/1027-4065-2021-66-1-31-38; Bartoszek A, Makaro A, Bartoszek A, et al. Walnut oil alleviates intestinal inflammation and restores intestinal barrier function in mice. Nutrients. 2020;12(5):1302. doi: https://doi.org/10.3390/nu12051302; Wang G, Yang X, Wang J, et al. Walnut green husk polysaccharides prevent obesity, chronic inflammatory responses, nonalcoholic fatty liver disease and colonic tissue damage in high-fat diet fed rats. Int J Biol Macromol. 2021;182:879–898. doi: https://doi.org/10.1016/j.ijbiomac.2021.04.047; Bourgonje AR, Feelisch M, Faber KN, et al. Oxidative stress and redox-modulating therapeutics in inflammatory bowel disease. Trends Mol Med. 2020;26(11):1034–1046. doi: https://doi.org/10.1016/j.molmed.2020.06.006; Miao F, Shan C, Ma T, et al. Walnut oil alleviates DSS–induced colitis in mice by inhibiting NLRP3 inflammasome activation and regulating gut microbiota. Microb Pathog. 2021;154:104866. doi: https://doi.org/10.1016/j.micpath.2021.104866; Zhao H, Li J, Zhao J, et al. Antioxidant effects of compound walnut oil capsule in mice aging model induced by D-galactose. Food Nutr Res. 2018:62. doi: https://doi.org/10.29219/fnr.v62.1371; Chen S, Wu X, Yu Z. Juglone suppresses inflammation and oxidative stress in colitis mice. Front Immunol. 2021;12:674341. doi: https://doi.org/10.3389/fimmu.2021.674341; Liu T, Zhang L, Joo D, et al. NF- B signaling in inflammation. Signal Transduct Target Ther. 2017;2:17023. doi: https://doi.org/10.1038/sigtrans.2017.23; Koh SJ, Choi YI, Kim Y, et al. Walnut phenolic extract inhibits nuclear factor kappaB signaling in intestinal epithelial cells, and ameliorates experimental colitis and colitis-associated colon cancer in mice. Eur J Nutr. 2018;58(4):1603–1613. doi: https://doi.org/10.1007/s00394-018-1704-3; Nobakht NAA, Lashgari NA, Roudsari NM, et al. Juglone mediates inflammatory bowel disease through inhibition of TLR-4/NF kappaB pathway in acetic acid-induced colitis in rats. Antiinflamm Antiallergy Agents Med Chem. 2023;22(2):92–103. doi: https://doi.org/10.2174/1871523022666230825105223; Qi Y, Wang X, Zhang Y, et al. Walnut-derived peptide improves cognitive impairment in colitis mice induced by dextran sodium sulfate via the microbiota–gut–brain axis (MGBA). J Agric Food Chem. 2023;71(49):19501–19515. doi: https://doi.org/10.1021/acs.jafc.3c04807; Hong Z, Shi C, Hu X, et al. Walnut protein peptides ameliorate DSS-induced uulcerative colitis damage in mice: an in silico analysis and in vivo investigation. J Agric Food Chem. 2023;71(42):15604–15619. doi: https://doi.org/10.1021/acs.jafc.3c04220; Wang D, Sun M, Zhang Y, et al. Enhanced therapeutic efficacy of a novel colon-specific nanosystem loading emodin on DSS-induced experimental colitis. Phytomedicine. 2020;78:153293. doi: https://doi.org/10.1016/j.phymed.2020.153293; Wang D, Mu Y, Dong H, et al. Chemical constituents of the ethyl acetate extract from diaphragma juglandis fructus and their inhibitory activity on nitric oxide production in vitro. Molecules. 2017;23(1):72. doi: https://doi.org/10.3390/molecules23010072; Miao F, Shan C, Shah SA, et al. D. Effect of walnut (Juglans sigillata) oil on intestinal antioxidant, anti-inflammatory, immunity, and gut microbiota modulation in mice. J Food Biochem. 2021;45(1):e13567. doi: https://doi.org/10.1111/jfbc.13567; He X, Chen D, Guo Y, et al. Walnut meal extracts rich in polyphenols mitigate insulin resistance and modulate gut microbiota in high fat diet-fed rats. J Med Food. 2022;25(6):618–629. doi: https://doi.org/10.1089/jmf.2021.K.0189; Authier H, Bardot V, Berthomier L, et al. Synergistic effects of licorice root and walnut leaf extracts on gastrointestinal candidiasis, inflammation and gut microbiota composition in mice. Microbiol Spectr. 2022;10(2):e0235521. doi: https://doi.org/0.1128/spectrum.02355-21; Hua Y, Liu R, Lu M, et al. Juglone regulates gut microbiota and Th17/Treg balance in DSS-induced ulcerative colitis. Int Immunopharmacol. 2021;97:107683. doi: https://doi.org/10.1016/j.intimp.2021.107683; Li L, Wang S, Zhang T, et al. Walnut peptide alleviates obesity,inflammation and dyslipidemia in mice fed a high-fat diet by modulating the intestinal flora and metabolites. Front Immunol. 2023;14:1305656. doi: https://doi.org/10.3389/fimmu.2023.1305656; Bamberger C, Rossmeier A, Lechner K, et al. A walnut-enriched diet affects gut microbiome in healthy caucasian subjects: a randomized, controlled trial. Nutrients. 2018;10(2):244. doi: https://doi.org/10.3390/nu10020244; Petersen KS, Chandra M, See JR, et al.Walnut consumption and gut microbial metabolism: results of an exploratory analysis from a randomized, crossover, controlled-feeding study. Clin Nutr. 2023;42(11):2258–2269. doi: https://doi.org/10.1016/j.clnu.2023.09.023; Holscher HD, Guetterman HM, Swanson KS, et al. Walnut consumption alters the gastrointestinal microbiota, microbially derived secondary bile acids, and health markers in healthy adults: a randomized controlled trial. J Nutr. 2018;148(6):861–867. doi: https://doi.org/10.1093/jn/nxy004; Tsoukas MA, Ko BJ, Witte TR, et al. Dietary walnut suppression of colorectal cancer in mice: Mediation by miRNA patterns and fatty acid incorporation. J Nutr Biochem. 2015;26(7):776–783. doi: https://doi.org/10.1016/j.jnutbio.2015.02.009; Song H, Cong Z, Wang C, et al. Research progress on Walnut oil: Bioactive compounds, health benefits, extraction methods, and medicinal uses. J Food Biochem. 2022;46(12):e14504. doi: https://doi.org/0.1111/jfbc.14504; Scaioli E, Liverany E, Belluzzi A. The imbalance between n-6/n-3 polyunsaturated fatty acids and inflammatory bowel disease: A comprehensive review and future therapeutic perspectives. Int J Mol Sci. 2017;18(12):2619. doi: https://doi.org/10.3390/ijms18122619; Federica U, Federica R, Silvio D, D’Alessio S. Actors and factors in the resolution of intestinal inflammation: Lipid mediators as a new approach to therapy in inflammatory bowel diseases. Front Immunol. 2017;8:1331. doi: https://doi.org/10.3389/fimmu.2017.01331; Zhang YG, Kan H, Chen SX, et al. Comparison of phenolic compounds extracted from Diaphragma juglandis fructus, walnut pellicle, and flowers of Juglans regia using methanol, ultrasonic wave, and enzyme assisted-extraction. Food Chem. 2020;321:126672. doi: https://doi.org/10.1016/j.foodchem.2020.126672; Wen S, He L, Zhong Z, et al. Stigmasterol restores the balance of Treg/Th17 cells by activating the butyrate-PPARγ axis in colitis. Front Immunol. 2021;12:741934. doi: https://doi.org/10.3389/fimmu.2021.741934; Li X, Guo M, Chi J, Ma J. Bioactive peptides fromwalnut residue protein. Molecules. 2020;25(6):1285. doi: https://doi.org/10.3390/molecules25061285; Grancieri M, Martino HS, Gonzalez de Mejia E. Protein digests and pure peptides from chia seed prevented adipogenesis and inflammation by inhibiting PPARγ and NF- B pathways in 3T3L-1 adipocytes. Nutrients. 2021;13(1):176. doi: https://doi.org/10.3390/nu13010176; https://www.pedpharma.ru/jour/article/view/2578

Availability: https://www.pedpharma.ru/jour/article/view/2578
https://doi.org/10.15690/pf.v22i1.2853

View record from BASE

14

Academic Journal

The Course of Dyskeratosis Congenita Masked by Crohn’s Disease in a Primary School-Age Child: Case Report ; Течение врожденного дискератоза под маской болезни Крона у ребенка младшего школьного возраста (клиническое наблюдение)

Authors: Evgeniy E. Bessonov, Andrey N. Surkov, Anna L. Arakelyan, Stanislav D. Getmanov, Natalia V. Zhurkova, Leyla S. Namazova-Baranova, Е. Е. Бессонов, А. Н. Сурков, Л. Д. Аракелян, С. Д. Гетманов, Н. В. Журкова, Л. С. Намазова-Баранова

Source: Pediatric pharmacology; Том 21, № 6 (2024); 503-509 ; Педиатрическая фармакология; Том 21, № 6 (2024); 503-509 ; 2500-3089 ; 1727-5776

Subject Terms: ониходистрофия, inflammatory bowel disease, esophageal stenosis, dental ulcer, onychodystrophy, воспалительные заболевания кишечника, стеноз пищевода, язва языка

File Description: application/pdf

Relation: https://www.pedpharma.ru/jour/article/view/2551/1653; Uria-Oficialdegui ML, Navarro S, Murillo-Sanjuan L, et al. Dyskeratosis congenita: natural history of the disease through the study of a cohort of patients diagnosed in childhood. Front Pediatr. 2023;11:1182476. https://doi.org/10.3389/fped.2023.1182476; Callea M, Martinelli D, Cammarata-Scalisi F, et al. Multisystemic Manifestations in Rare Diseases: The Experience of Dyskeratosis Congenita. Genes (Basel). 2022;13(3):496. https://doi.org/10.3390/genes13030496; Savage SA. Dyskeratosis congenita and telomere biology disorders. Hematology Am Soc Hematol Educ Program. 2022;2022(1):637–648. https://doi.org/10.1182/hematology.2022000394; AlSabbagh MM. Dyskeratosis congenita: a literature review. J Dtsch Dermatol Ges. 2020;18(9):943–967. https://doi.org/10.1111/ddg.14268; Khattab S, Nasser H, Al-Janabi MH, Hasan F. Dyskeratosis congenita: a rare case report. Oxf Med Case Reports. 2024;2024(5):omae049. https://doi.org/10.1093/omcr/omae049; Rolles B, Tometten M, Meyer R, et al. Inherited Telomere Biology Disorders: Pathophysiology, Clinical Presentation, Diagnostics, and Treatment. Transfus Med Hemother. 2024;51(5):292–309. https://doi.org/10.1159/000540109; Roka K, Solomou E, Kattamis A, Stiakaki E. Telomere biology disorders: from dyskeratosis congenita and beyond. Postgrad Med J. 2024;100(1190):879–889. https://doi.org/10.1093/postmj/qgae102; Garus A, Autexier C. Dyskerin: an essential pseudouridine synthase with multifaceted roles in ribosome biogenesis, splicing, and telomere maintenance. RNA. 2021;27(12):1441–1458. https://doi.org/10.1261/rna.078953.121; Шелыгин Ю.А., Ивашкин В.Т., Ачкасов С.И. и др. Клинические рекомендации. Болезнь Крона (К50), взрослые // Колопроктология. — 2023. — Т. 22. — № 3. — С. 10–49. — https://doi.org/10.33878/2073-7556-2023-22-3-10-49; Бекин А.С., Дьяконова Е.Ю., Сурков А.Н. и др. Болезнь Крона у детей: современное состояние проблемы // Педиатрия. Журнал им. Г.Н. Сперанского. — 2021. — Т. 100. — № 6. — С. 78–85. — https://doi.org/10.24110/0031-403X-2021-100-6-78-85; Lee J, Cheeseman E, Matheus M, Kasi N. A Primary Gastrointestinal Presentation and Novel Genetic Variant of Dyskeratosis Congenita in a Pediatric Patient. JPGN Rep. 2022;3(3):e242. https://doi.org/10.1097/PG9.0000000000000242; Knight SW, Heiss NS, Vulliamy TJ, et al. Unexplained aplastic anaemia, immunodeficiency, and cerebellar hypoplasia (HoyeraalHreidarsson syndrome) due to mutations in the dyskeratosis congenita gene, DKC1. Br J Haematol. 1999;107(2):335–339. https://doi.org/10.1046/j.1365-2141.1999.01690.x.; Yaghmai R, Kimyai-Asadi A, Rostamiani K, et al. Overlap of dyskeratosis congenita with the Hoyeraal-Hreidarsson syndrome. J Pediatr. 2000;136(3):390–393. https://doi.org/10.1067/mpd.2000.; Tummala H, Walne A, Dokal I. The biology and management of dyskeratosis congenita and related disorders of telomeres. Expert Rev Hematol. 2022;15(8):685–696. https://doi.org/10.1080/17474086.2022.2108784; Townsley DM, Dumitriu B, Liu D, et al. Danazol treatment for telomere diseases. N Engl J Med. 2016;374(20):1922–1931. https://doi.org/10.1056/NEJMoa1515319; https://www.pedpharma.ru/jour/article/view/2551